» Articles » PMID: 28339967

Placental Transporter Localization and Expression in the Human: the Importance of Species, Sex, and Gestational Age Differences†

Overview
Journal Biol Reprod
Date 2017 Mar 25
PMID 28339967
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The placenta is a critical organ during pregnancy, essential for the provision of an optimal intrauterine environment, with fetal survival, growth, and development relying on correct placental function. It must allow nutritional compounds and relevant hormones to pass into the fetal bloodstream and metabolic waste products to be cleared. It also acts as a semipermeable barrier to potentially harmful chemicals, both endogenous and exogenous. Transporter proteins allow for bidirectional transport and are found in the syncytiotrophoblast of the placenta and endothelium of fetal capillaries. The major transporter families in the human placenta are ATP-binding cassette (ABC) and solute carrier (SLC), and insufficiency of these transporters may lead to deleterious effects on the fetus. Transporter expression levels are gestation-dependent and this is of considerable clinical interest as levels of drug resistance may be altered from one trimester to the next. This highlights the importance of these transporters in mediating correct and timely transplacental passage of essential compounds but also for efflux of potentially toxic drugs and xenobiotics. We review the current literature on placental molecular transporters with respect to their localization and ontogeny, the influence of fetal sex, and the relevance of animal models. We conclude that a paucity of information exists, and further studies are required to unlock the enigma of this dynamic organ.

Citing Articles

[Research advances in the transplacental transfer efficiencies of environmental pollutants].

Yuan K, Xiong J, Yuan B Se Pu. 2024; 43(1):13-21.

PMID: 39722617 PMC: 11686480. DOI: 10.3724/SP.J.1123.2024.07002.


Distribution of polybrominated diphenyl ethers (PBDEs) in placental tissues of maternal and fetal origin in exposed Wistar rats and associations with thyroid hormone levels.

Gaballah S, Hormon B, Nelson G, Cao J, Hoffman K, Patisaul H Toxicol Sci. 2024; 204(1):20-30.

PMID: 39626304 PMC: 11879049. DOI: 10.1093/toxsci/kfae151.


The Role of ABCB1, ABCG2, and SLC Transporters in Pharmacokinetic Parameters of Selected Drugs and Their Involvement in Drug-Drug Interactions.

Kielbowski K, Krol M, Bakinowska E, Pawlik A Membranes (Basel). 2024; 14(11).

PMID: 39590609 PMC: 11596214. DOI: 10.3390/membranes14110223.


Early-life exposure to per- and polyfluoroalkyl substances: Analysis of levels, health risk and binding abilities to transport proteins.

Xu Y, Sui X, Li J, Zhang L, Wang P, Liu Y Eco Environ Health. 2024; 3(3):308-316.

PMID: 39258237 PMC: 11385757. DOI: 10.1016/j.eehl.2024.04.007.


Unveiling the human fetal-maternal interface during the first trimester: biophysical knowledge and gaps.

Masserdotti A, Gasik M, Grillari-Voglauer R, Grillari J, Cargnoni A, Chiodelli P Front Cell Dev Biol. 2024; 12:1411582.

PMID: 39144254 PMC: 11322133. DOI: 10.3389/fcell.2024.1411582.


References
1.
Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M . Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet. 1999; 353(9148):210-1. DOI: 10.1016/S0140-6736(05)77221-4. View

2.
Staud F, Cerveny L, Ceckova M . Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target. 2012; 20(9):736-63. DOI: 10.3109/1061186X.2012.716847. View

3.
He L, Vasiliou K, Nebert D . Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics. 2009; 3(2):195-206. PMC: 2752037. DOI: 10.1186/1479-7364-3-2-195. View

4.
Parisi M, Spong C, Zajicek A, Guttmacher A . We don't know what we don't study: the case for research on medication effects in pregnancy. Am J Med Genet C Semin Med Genet. 2011; 157C(3):247-50. PMC: 3140632. DOI: 10.1002/ajmg.c.30309. View

5.
Munic V, Kelneric Z, Mikac L, Erakovic Haber V . Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Eur J Pharm Sci. 2010; 41(1):86-95. DOI: 10.1016/j.ejps.2010.05.016. View